Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Transforming growth factor-B1 and matrix metalloproteinase-7 promoter variants induce risk for Helicobacter pylori-associated gastric precancerous lesions.

Achyut BR, Ghoshal UC, Moorchung N, Mittal B.

DNA Cell Biol. 2009 Jun;28(6):295-301. doi: 10.1089/dna.2008.0842.

PMID:
19317620
2.

Association of Toll-like receptor-4 (Asp299Gly and Thr399Ileu) gene polymorphisms with gastritis and precancerous lesions.

Achyut BR, Ghoshal UC, Moorchung N, Mittal B.

Hum Immunol. 2007 Nov;68(11):901-7. Epub 2007 Nov 5.

PMID:
18082569
3.

Helicobacter pylori cytotoxin-associated genotype and gastric precancerous lesions.

Plummer M, van Doorn LJ, Franceschi S, Kleter B, Canzian F, Vivas J, Lopez G, Colin D, Muñoz N, Kato I.

J Natl Cancer Inst. 2007 Sep 5;99(17):1328-34. Epub 2007 Aug 28.

PMID:
17728213
4.

Synergistic effect of IL-1β and TNF-α polymorphisms on the H. pylori-related gastric pre-malignant condition.

Tahara T, Shibata T, Yamashita H, Yoshioka D, Okubo M, Yonemura J, Kamiya Y, Ishizuka T, Nakagawa Y, Nagasaka M, Iwata M, Nakamura M, Hirata I, Arisawa T.

Hepatogastroenterology. 2012 Nov-Dec;59(120):2416-20. doi: 10.5754/hge10605.

PMID:
23169178
5.

Age and severity of mucosal lesions influence the performance of serologic markers in Helicobacter pylori-associated gastroduodenal pathologies.

Camorlinga-Ponce M, Flores-Luna L, Lazcano-Ponce E, Herrero R, Bernal-Sahagún F, Abdo-Francis JM, Aguirre-García J, Muñoz N, Torres J.

Cancer Epidemiol Biomarkers Prev. 2008 Sep;17(9):2498-504. doi: 10.1158/1055-9965.EPI-08-0289.

6.

Interleukin-10 (-819 C/T) and tumor necrosis factor-alpha (-308 G/A) gene variants influence gastritis and lymphoid follicle development.

Achyut BR, Tripathi P, Ghoshal UC, Moorchung N, Mittal B.

Dig Dis Sci. 2008 Mar;53(3):622-9. Epub 2007 Aug 24.

PMID:
17717744
7.

Association of polymorphisms in myeloperoxidase and catalase genes with precancerous changes in the gastric mucosa of patients at inner-city hospitals in New York.

Steenport M, Eom H, Uezu M, Schneller J, Gupta R, Mustafa Y, Villanueva R, Straus EW, Raffaniello RD.

Oncol Rep. 2007 Jul;18(1):235-40.

PMID:
17549373
8.

Relationship between Helicobacter pylori babA2 status with gastric epithelial cell turnover and premalignant gastric lesions.

Yu J, Leung WK, Go MY, Chan MC, To KF, Ng EK, Chan FK, Ling TK, Chung SC, Sung JJ.

Gut. 2002 Oct;51(4):480-4.

9.

Virulence factors of Helicobacter pylori vacA increase markedly gastric mucosal TGF-β1 mRNA expression in gastritis patients.

Rahimian G, Sanei MH, Shirzad H, Azadegan-Dehkordi F, Taghikhani A, Salimzadeh L, Hashemzadeh-Chaleshtori M, Rafieian-Kopaei M, Bagheri N.

Microb Pathog. 2014 Feb-Mar;67-68:1-7. doi: 10.1016/j.micpath.2013.12.006. Epub 2014 Jan 21.

PMID:
24462401
10.

Polymorphisms of matrix metalloproteinase-7 and chymase are associated with susceptibility to and progression of gastric cancer in Japan.

Sugimoto M, Furuta T, Kodaira C, Nishino M, Yamade M, Ikuma M, Sugimura H, Hishida A.

J Gastroenterol. 2008;43(10):751-61. doi: 10.1007/s00535-008-2221-6. Epub 2008 Oct 29.

PMID:
18958543
11.

Relation of atrophic gastritis with Helicobacter pylori-CagA(+) and interleukin-1 gene polymorphisms.

Sierra R, Une C, Ramirez V, Alpizar-Alpizar W, Gonzalez MI, Ramirez JA, De Mascarel A, Cuenca P, Perez-Perez G, Megraud F.

World J Gastroenterol. 2008 Nov 14;14(42):6481-7.

12.

STAT3 polymorphism and Helicobacter pylori CagA strains with higher number of EPIYA-C segments independently increase the risk of gastric cancer.

Rocha GA, Rocha AM, Gomes AD, Faria CL Jr, Melo FF, Batista SA, Fernandes VC, Almeida NB, Teixeira KN, Brito KS, Queiroz DM.

BMC Cancer. 2015 Jul 19;15:528. doi: 10.1186/s12885-015-1533-1.

13.

Gastric precancerous lesions are associated with gene variants in Helicobacter pylori-susceptible ethnic Malays.

Maran S, Lee YY, Xu S, Rajab NS, Hasan N, Syed Abdul Aziz SH, Majid NA, Zilfalil BA.

World J Gastroenterol. 2013 Jun 21;19(23):3615-22. doi: 10.3748/wjg.v19.i23.3615.

14.

[Genotyping of Helicobacter pylori virulence factors vacA and cagA in individuals from two regions in Colombia with opposing risk for gastric cancer].

Trujillo E, Martínez T, Bravo MM.

Biomedica. 2014 Oct-Dec;34(4):567-73. doi: 10.1590/S0120-41572014000400009. Spanish.

15.

Cancer precursor lesions in intact stomach Helicobacter pylori gastritis and in resected stomach gastritis.

Giuliani A, Spada S, Corona M, Demoro M, Di Bari M, Ricciardulli T, Galati G, Caporale A, Tocchi A, Angelico F.

J Exp Clin Cancer Res. 2003 Sep;22(3):371-8.

PMID:
14582693
16.

Role of cyclooxygenase-2 functional gene polymorphisms in Helicobacter pylori induced gastritis and gastric atrophy.

Achyut BR, Ghoshal UC, Moorchung N, Mittal B.

Mol Cell Biochem. 2009 Jan;321(1-2):103-9. doi: 10.1007/s11010-008-9924-0. Epub 2008 Sep 30.

PMID:
18825488
17.

Risk of lymphoid follicle development in patients with chronic antral gastritis: role of endoscopic features, histopathological parameters, CagA status and interleukin-1 gene polymorphisms.

Achyut BR, Moorchung N, Srivastava AN, Gupta NK, Mittal B.

Inflamm Res. 2008 Feb;57(2):51-6. doi: 10.1007/s00011-007-7033-2.

PMID:
18288454
18.

Risk of advanced gastric precancerous lesions in Helicobacter pylori infected subjects is influenced by ABO blood group and cagA status.

Rizzato C, Kato I, Plummer M, Muñoz N, Stein A, Jan van Doorn L, Franceschi S, Canzian F.

Int J Cancer. 2013 Jul 15;133(2):315-22. doi: 10.1002/ijc.28019. Epub 2013 Feb 12.

19.
20.

Toll-like receptor 1 and 10 polymorphisms, Helicobacter pylori susceptibility and risk of gastric lesions in a high-risk Chinese population.

Tang FB, Li ZX, Wang YM, Zhang L, Ma JL, Zhou T, Zhang Y, Gao JJ, Wu S, Yang T, You WC, Pan KF.

Infect Genet Evol. 2015 Apr;31:263-9. doi: 10.1016/j.meegid.2015.02.005. Epub 2015 Feb 14.

PMID:
25687912

Supplemental Content

Support Center